Evidence map›Paper›PMID 26069966›Full record

ArticlePloS one2015

Reduced IL-17A Secretion Is Associated with High Levels of Pneumococcal Nasopharyngeal Carriage in Fijian Children.

Edwin Hoe, Laura K Boelsen, Zheng Quan Toh, Guang Wen Sun, Ghee Chong Koo, Anne Balloch, Rachel Marimla, Eileen M Dunne, Lisi Tikoduadua, Fiona M Russell and 3 more

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Panel 3: Genomics, precision medicine and targeted therapies.International journal of pediatric otorhinolaryngology · 2020
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Edwin HoePneumococcal Research, Murdoch Childrens Research Institute, Melbourne, Australia.
Laura K BoelsenPneumococcal Research, Murdoch Childrens Research Institute, Melbourne, Australia; Department of Paediatrics, The University of Melbourne, Melbourne, Australia.
Zheng Quan TohPneumococcal Research, Murdoch Childrens Research Institute, Melbourne, Australia.
Guang Wen SunSchool of Applied Science, Republic Polytechnic, Singapore, Singapore.
Ghee Chong KooSchool of Applied Science, Republic Polytechnic, Singapore, Singapore.
Anne BallochPneumococcal Research, Murdoch Childrens Research Institute, Melbourne, Australia.
Rachel MarimlaPneumococcal Research, Murdoch Childrens Research Institute, Melbourne, Australia.
Eileen M DunnePneumococcal Research, Murdoch Childrens Research Institute, Melbourne, Australia.
Lisi TikoduaduaMinistry of Health, Suva, Fiji.
Fiona M RussellPneumococcal Research, Murdoch Childrens Research Institute, Melbourne, Australia; Centre for International Child Health, Department of Paediatrics, The University of Melbourne, Melbourne, Australia.
Catherine SatzkePneumococcal Research, Murdoch Childrens Research Institute, Melbourne, Australia; Department of Paediatrics, The University of Melbourne, Melbourne, Australia; The Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
E Kim MulhollandPneumococcal Research, Murdoch Childrens Research Institute, Melbourne, Australia; London School of Hygiene and Tropical Medicine, London, United Kingdom.
Paul V LicciardiPneumococcal Research, Murdoch Childrens Research Institute, Melbourne, Australia; Department of Paediatrics, The University of Melbourne, Melbourne, Australia.

Funding

The safety of pneumococcal polysaccharide vaccine in children - a followup study.R01AI085198 · NIAID · MURDOCH CHILDREN'S RESEARCH INSTITUTE · PI MULHOLLAND, EDWARD KIM · 2010 to 2011
$936k
NIAID NIH HHS 1R01AI085198-01A1NIAID NIH HHS R01 AI085198
6 · The paper itself

Abstract

Streptococcus pneumonia (the pneumococcus) is the leading vaccine preventable cause of serious infections in infants under 5 years of age. The major correlate of protection for pneumococcal infections is serotype-specific IgG antibody. More recently, antibody-independent mechanisms of protection have also been identified. Preclinical studies have found that IL-17 secreting CD4+ Th17 cells in reducing pneumococcal colonisation. This study assessed IL-17A levels in children from Fiji with high and low pneumococcal carriage density, as measured by quantitative real-time PCR (qPCR). We studied Th17 responses in 54 children who were designated as high density carriers (N=27, >8.21x10(5) CFU/ml) or low density carriers (N=27, <1.67x10(5) CFU/ml). Blood samples were collected, and isolated peripheral blood mononuclear cells (PBMCs) were stimulated for 6 days. Supernatants were harvested for cytokine analysis by multiplex bead array and/or ELISA. Th17 cytokines assayed included IL-17A, IL-21, IL-22 as well as TNF-α, IL-10, TGF-β, IL-6, IL-23 and IFNγ. Cytokine levels were significantly lower in children with high density pneumococcal carriage compared with children with low density carriage for IL-17A (p=0.002) and IL-23 (p=0.04). There was a trend towards significance for IL-22 (p=0.057) while no difference was observed for the other cytokines. These data provide further support for the role of Th17-mediated protection in humans and suggest that these cytokines may be important in the defence against pneumococcal carriage.

Indexed as

Bacterial LoadChildChinaFemaleHumansInterferon-gammaInterleukin-17MaleNasopharynxStreptococcal InfectionsTumor Necrosis Factor-alphaInterferon-gammaInterleukin-17Tumor Necrosis Factor-alpha

Identifiers

PMID26069966
PMCPMC4466549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.